The Global Beta-lactam and Beta-lactamase Inhibitors Market study includes a rounded approach for the market by analysing past data and analysis uncovered from the leading vendors. Overall, the ...

The Beta-lactam and Beta-lactamase Inhibitors Market encompasses a wide range of antibiotics and enzyme inhibitors used in the treatment of various bacterial infections. Beta-lactams are a class of ...

Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Astellas Pharma Inc., Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Meiji ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated ...

Please provide your email address to receive an email when new articles are posted on . A metallo-beta-lactam inhibitor could help fight resistance to beta-lactam antibiotics. MK-3402 was found to be ...

WALTHAM, Mass.--(BUSINESS WIRE)--Entasis Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced initiation ...

Pune, Maharashtra, India, December 17 2020 (Wiredrelease) Allied Analytics –:Increase in demand for antimicrobial resistance medication play a major role in the growth of the beta-lactam and ...

Pfizer has just completed phase 3 trials of a new antibiotic that's active against highly resistant Gram-negative infections. It's a real superbug fighter. But what took so long? Once upon a time in a ...

MONTREAL, QUEBEC -- MethylGene Inc. announced that it has received notice today that Merck intends to terminate the exclusive license and research collaboration agreement, entered into by the ...

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global beta lactam and beta lactamase inhibitors market size is estimated to grow by USD 8.4 billion from ...

WHITEHOUSE STATION, N.J.--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated relebactam (previously ...